Edwards Lifesciences (EW) Raising Estimates, PT on Better Than Expected Sapien 3 Data - Leerink Partners
Tweet Send to a Friend
Leerink Partners analyst, Danielle Antalffy, raised her PT on Edwards Lifesciences by nearly 25% to $115 to account for better ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
